AMN Healthcare Services

AMNNYSEUSD

THESIS ALERT

Email me when the AMN thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$37.90
+$0.09 (+0.24%)Today 1M +3.53%
After hours$37.900.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$37.81
Prior regular-session close from the quote source.
$37.19–$38.55
Regular-session low and high so far today.
491.2K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 4 projected
Projected for 2027-02-04 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$14.97–$49.62
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own AMN if AMN is a post-pandemic healthcare staffing recovery bet: the business has real network value and cash generation, but the burden is proving that hospital labor demand and bill-rate spreads have stabilized rather than structurally.

AMN price history

Latest price$37.90Today+$0.09 (+0.24%)
AMN +4.18%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Hospitals continue to need outsourced access to qualified clinicians, so AMN's broad professional network remains a necessary capacity tool rather than a pandemic-only service.WeakeningMateriality: High

    Profile description says AMN has one of the nation's broadest networks of highly-qualified healthcare professionals. If this holds, revenue can stabilize and recover; if it breaks, AMN's core demand pool is structurally smaller.

    Watch: Large hospital systems permanently replace travel clinicians with internal float pools and lower contract-labor targets.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Profile description says AMN has one of the nation's broadest networks of highly-qualified healthcare professionals.

    Open source ↗
  • AMN can defend its pay-bill spread because scale, compliance, credentialing, and client service matter more than simply matching clinicians at the lowest price.WeakeningMateriality: High

    GAAP annual gross profit remained substantial at $774.058 million in FY2025. If AMN keeps pricing power, revenue recovery can translate into profit; if spreads compress, growth may not create value.

    Watch: Hospital procurement departments force lower bill rates across vendor panels and managed-service-provider renewals.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross profit remained substantial at $774.058 million in FY2025.

    Open source ↗
  • Management can resize AMN's cost base after the demand reset so the platform returns to operating profitability without needing another pandemic-level staffing spike.HoldingMateriality: Medium

    GAAP annual operating loss improved from $102.673 million in FY2024 to $55.472 million in FY2025. This determines whether AMN is a normalized earnings recovery or a structurally overbuilt platform.

    Watch: Corporate, technology, and compliance costs prove too fixed for the lower revenue base.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating loss improved from $102.673 million in FY2024 to $55.472 million in FY2025.

    Open source ↗
  • AMN's asset-light staffing model and working-capital discipline allow it to generate operating cash through the downturn, giving the company time to repair profitability.StrengtheningMateriality: Medium

    GAAP annual operating cash flow was positive at $269.457 million in FY2025 despite a GAAP net loss. Positive cash flow reduces financing risk and gives management flexibility even while GAAP earnings are weak.

    Watch: A demand recovery consumes working capital faster than collections, turning growth into a cash drain.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow was positive at $269.457 million in FY2025 despite a GAAP net loss.

    Open source ↗
  • AMN can use cash generation and asset-light operations to keep balance-sheet risk manageable while waiting for staffing demand to normalize.HoldingMateriality: Medium

    Total liabilities declined from $2.093 billion at FY2023 year-end to $1.709 billion at FY2024 year-end and $1.452 billion at FY2025 year-end. If leverage pressure stays contained, shareholders can participate in recovery; if not, debt holders or refinancing terms capture the upside.

    Watch: A prolonged staffing slump reduces cash flow before remaining debt and lease obligations are reduced.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Total liabilities declined from $2.093 billion at FY2023 year-end to $1.709 billion at FY2024 year-end and $1.452 billion at FY2025.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Hospitals continue to need outsourced access to qualified clinicians, so AMN's broad professional network remains a necessary capacity tool rather than a pandemic-only service. If this holds, revenue can stabilize and recover; if it breaks, AMN's core demand pool is structurally smaller.

AMN can defend its pay-bill spread because scale, compliance, credentialing, and client service matter more than simply matching clinicians at the lowest price. If AMN keeps pricing power, revenue recovery can translate into profit; if spreads compress, growth may not create value.

Management can resize AMN's cost base after the demand reset so the platform returns to operating profitability without needing another pandemic-level staffing spike. This determines whether AMN is a normalized earnings recovery or a structurally overbuilt platform.

AMN's asset-light staffing model and working-capital discipline allow it to generate operating cash through the downturn, giving the company time to repair profitability. Positive cash flow reduces financing risk and gives management flexibility even while GAAP earnings are weak.

AMN can use cash generation and asset-light operations to keep balance-sheet risk manageable while waiting for staffing demand to normalize. If leverage pressure stays contained, shareholders can participate in recovery; if not, debt holders or refinancing terms capture the upside.

All standing thesis claims
Original report summary

AMN is a post-pandemic healthcare staffing recovery bet: the business has real network value and cash generation, but the burden is proving that hospital labor demand and bill-rate spreads have stabilized rather than structurally.

Evidence assessed Nov 12, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for AMN Healthcare Services

Where the evidence on AMN Healthcare Services disagrees: Mixed on the latest evidence (Nov 12, 2026). Of its 5 thesis points, 1 strengthening, 2 holding and 2 weakening.

Bull case: what the evidence supports

  • Management can resize AMN's cost base after the demand reset so the platform returns to operating profitability without needing another pandemic-level staffing spike.

    sec.gov ↗

  • AMN's asset-light staffing model and working-capital discipline allow it to generate operating cash through the downturn, giving the company time to repair profitability.

    sec.gov ↗

  • AMN can use cash generation and asset-light operations to keep balance-sheet risk manageable while waiting for staffing demand to normalize.

    sec.gov ↗

Bear case: what the evidence questions

  • Hospitals continue to need outsourced access to qualified clinicians, so AMN's broad professional network remains a necessary capacity tool rather than a pandemic-only service.

    sec.gov ↗

  • AMN can defend its pay-bill spread because scale, compliance, credentialing, and client service matter more than simply matching clinicians at the lowest price.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · AMN Healthcare Services

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed AMN Healthcare Services’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    AMN Healthcare Services filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    AMN Healthcare Services filed an SEC 8-K on 2026-05-04: Director or principal officer change. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large hospital systems permanently replace travel clinicians with internal float pools and lower contract-labor targets.
  • Hospital procurement departments force lower bill rates across vendor panels and managed-service-provider renewals.
  • Corporate, technology, and compliance costs prove too fixed for the lower revenue base.
  • A demand recovery consumes working capital faster than collections, turning growth into a cash drain.
  • A prolonged staffing slump reduces cash flow before remaining debt and lease obligations are reduced.

AMN news

Loading headlines…

Financial statements

AMN income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

AMN: quick answers

When does AMN Healthcare Services (AMN) report earnings next?
AMN Healthcare Services's next results are projected for February 4, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
What is AMN's short interest?
As of October 30, 2026, 4.3M AMN shares were sold short, 11.1% of its shares outstanding, up 11.5% from the count before. At the stock's average daily volume that is 3.9 days to cover. FINRA publishes the count twice a month. AMN short interest history
Have members of Congress traded AMN?
19 trades in AMN have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed AMN trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.